Company Filing History:
Years Active: 2013-2019
Title: Michael Schilling: Innovator in Microbial Biotechnology
Introduction
Michael Schilling is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of microbial biotechnology, particularly in the development of genetically modified organisms for various applications. With a total of 3 patents to his name, Schilling's work has the potential to impact various industries.
Latest Patents
One of Schilling's latest patents involves a microorganism designed for expressing a human membrane protein. This invention relates to an isolated, genetically modified, living non-mammal organism that exhibits increased HMG-CoA-reductase activity compared to the wild type. Additionally, it has reduced C24-methyltransferase and/or delta22-desaturase activity compared to the wild type. The organism is characterized by increased dehydrocholesterol-delta70-reductase activity compared to the wild type. The invention also encompasses various uses of such an organism, a test kit comprising the organism, and a membrane extract derived from it.
Career Highlights
Throughout his career, Michael Schilling has worked with notable companies such as Novozymes A/S and BASF SE Corporation. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in biotechnology.
Collaborations
Some of Schilling's notable coworkers include Christine Lang and Andreas Raab. Their collaboration has likely fostered a creative environment that encourages innovation and the development of groundbreaking technologies.
Conclusion
Michael Schilling's contributions to microbial biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in the use of genetically modified organisms.